BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| (2R,3R,4R,5R)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-chloro-4-methyltetrahydrofuran-3-yl benzoate | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: (2R,3R,4R,5R)-5-(4-benzoylamino-2-oxopyrimidine-1(2H)-yl)-2-((benzoyloxy)methyl)-4-Chloro-4-methyltetrahydrofuran-3-ylbenzoate. Grade: 95%. CAS No. 1496551-70-2. Molecular formula: C31H26ClN3O7. Mole weight: 588.01. |  |
| (2R,3R,4R,5R)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-hydroxy-4-methyltetrahydrofuran-3-yl benzoate | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grade: 95%. CAS No. 863329-64-0. Molecular formula: C31H27N3O8. Mole weight: 569.56. | |
| (2R,3R,4R,5R)-5-(4-(Benzoyloxy)-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl Benzoate | (2R,3R,4R,5R)-5-(4-(Benzoyloxy)-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl Benzoate is an intermediate in synthesizing PSI 6130, which is an experimental treatment for hepatitis C. PSI 6130 is a member of a class of antiviral drugs known as nucleoside polymerase inhibitors. PSI 6130 inhibits the hepatitis C virus RNA dependant RNA polymerase called NS5B. Molecular formula: C31H25FN2O8. Mole weight: 572.54. | |
| (2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite | (2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite is an intricate and versatile compound in the realm of biomedical research. Its utilization lies predominantly in the synthesis of nucleotides and nucleic acids, catering to an array of molecular biology and drug discovery applications. This product can serve as a paramount resource for drug development investigations, gene expression analysis, and genetic scrutiny. CAS No. 252770-65-3. Molecular formula: C40H47FN7O6P. Mole weight: 771.82. | |
| (2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)-4-methyloxolan-3-ol | (2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)-4-methyloxolan-3-ol is a highly potent and specific pharmaceutical compound utilized in the research of viral infections attributed to specific strains of the herpes simplex virus. This remarkable medicinal entity exerts its influence through the robust suppression of viral DNA polymerase, thereby impeding viral replication processes. Synonyms: 2'-deoxy-2'-fluoro-2'-C-methyladenosine. CAS No. 818374-78-6. Molecular formula: C11H14FN5O3. Mole weight: 283.26. | |
| (2R,3R,4R,5S)-1-[2-(Acetyloxy)ethyl]-2-[(acetyloxy)methyl]-3,4,5-piperidinetriol 3,4,5-Triacetate | (2R,3R,4R,5S)-1-[2-(Acetyloxy)ethyl]-2-[(acetyloxy)methyl]-3,4,5-piperidinetriol 3,4,5-Triacetate is an intermediate in the synthesis of N-(2-Hydroxyethyl)-1-deoxygalactonojirimycin Hydrochloride, which is an α-Glycosidase inhibitor. Synonyms: 3,4,5-Piperidinetriol, 1-[2-(acetyloxy)ethyl]-2-[(acetyloxy)methyl]-, 3,4,5-triacetate, (2R,3R,4R,5S)-. CAS No. 1178861-41-0. Molecular formula: C18H27NO10. Mole weight: 417.41. | |
| (2R,3R,4R,5S)-3,4,5-Trihydroxy-2-(hydroxymethyl)-1-piperidinepropanoic acid | (2R,3R,4R,5S)-3,4,5-Trihydroxy-2-(hydroxymethyl)-1-piperidinepropanoic acid is a compound in the biomedical field, exhibiting promising prospects in the research of notable maladies like diabetes, cardiovascular pathologies, and neurological anomalies. Synonyms: 1-Piperidinepropanoic acid, 3,4,5-trihydroxy-2-(hydroxymethyl)-, (2R,3R,4R,5S)-; 1-Piperidinepropanoic acid, 3,4,5-trihydroxy-2-(hydroxymethyl)-, [2R-(2α,3β,4α,5β)]-; N-(2-carboxyethyl)-1,5-dideoxy-1,5-imino-d-glucitol. CAS No. 78013-18-0. Molecular formula: C9H17NO6. Mole weight: 235.24. | |
| (2R,3R,4R,5S)-3,4,5-Trihydroxy-2-piperidinecarboxylic acid | Important bioactive principle in established anti-inflammatory herbal medicines. Synonyms: ido-BR1; idoBR1; 2-Piperidinecarboxylic acid, 3,4,5-trihydroxy-, (2R,3R,4R,5S)-; 2-Piperidinecarboxylic acid, 3,4,5-trihydroxy-, [2R-(2α,3α,4β,5α)]-. Grade: ≥98% by HPLC. CAS No. 108428-44-0. Molecular formula: C6H11NO5. Mole weight: 177.16. | |
| (2R,3R,4R,5S)-3,4,5-Trihydroxy-N-methyl-2-piperidinecarboxamide | (2R,3R,4R,5S)-3,4,5-Trihydroxy-N-methyl-2-piperidinecarboxamide is a complex chemical compound used in biomedicine. It plays an important role in the development of drugs treating neurodegenerative diseases like Alzheimer's and Parkinson's due to its distinctive molecular structure. Synonyms: 2-Piperidinecarboxamide, 3,4,5-trihydroxy-N-methyl-, (2R,3R,4R,5S)-. CAS No. 1207673-93-5. Molecular formula: C7H14N2O4. Mole weight: 190.20. | |
| (2R,3R,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)-N-methyl-2-pyrrolidine carboxamide | (2R,3R,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)-N-methyl-2-pyrrolidine carboxamide, a compound of immense value, finds extensive utilization in the biomedical sector. Its remarkable molecular architecture imparts it with exceptional potential to serve as a targeted therapy agent for a wide array of diseases. As a result, it represents a promising avenue for future research endeavors in drug discovery and development, particularly in the identification and exploration of novel medications specific to particular conditions. Synonyms: 2-Pyrrolidinecarboxamide, 3,4-dihydroxy-5-(hydroxymethyl)-N-methyl-, (2R,3R,4R,5S)-; (2R,3R,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)-N-methyl-2-pyrrolidinecarboxamide. CAS No. 1591782-91-0. Molecular formula: C7H14N2O4. Mole weight: 190.20. | |
| (2R,3R,4R,5S)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-chloro-4-methyltetrahydrofuran-3-yl benzoate | (2R,3R,4R,5S)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-chloro-4-methyltetrahydrofuran-3-yl benzoate, a potent anticancer drug, has been shown to provide treatment benefits in diverse forms of cancer like pancreatic, lung, and colon cancers. Acting through the suppression of certain cancer-related proteins, it successfully impedes cancerous cell growth and division, thereby deterring the progression of this morbidity. Its structural and functional attributes render it an indispensable agent in the fight against cancer. Molecular formula: C31H26ClN3O7. Mole weight: 588.01. | |
| (2R,3R,4R,5S,6R)-2-(acetoxymethyl)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate | (2R,3R,4R,5S,6R)-2-(acetoxymethyl)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate is an impurity of Empagliflozin, a medication indicated for type 2 diabetes treatment. CAS No. 1620758-27-1. Molecular formula: C31H35ClO11. Mole weight: 619.06. | |
| (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(2-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate | (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(2-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). CAS No. 2040305-09-5. Molecular formula: C29H33ClO10. Mole weight: 577.02. | |
| (2R,3R,4S)-2-[[(2R,3S,4R,5R,6S)-4,6-Dihydroxy-2-(hydroxymethyl)-5-(sulfonatoamino)oxan-3-yl]oxy]-4-hydroxy-3-(sulfonatooxy)-3,4-dihydro-2H-pyran-6-carboxylate | A biomedical product used in the research of blood clotting disorders. This compound is derived from heparin, a drug commonly used to prevent and study deep vein thrombosand pulmonary embolism. CAS No. 98797-50-3. Molecular formula: C12H18NO16S2. Mole weight: 496.4. | |
| (2R,3R,4S)-2-(Acetoxymethyl)-5-((2-amino-6-hydroxy-9H-purin-9-yl)methyl)tetrahydrofuran-3,4-diyl diacetate | (2R,3R,4S)-2-(Acetoxymethyl)-5-((2-amino-6-hydroxy-9H-purin-9-yl)methyl)tetrahydrofuran-3,4-diyl diacetate is a complex pharmaceutical remedy, a vital tool in the battle against viral infections, prominently including HIV and hepatitis C. Its ability to slow replication and progression of the diseases it targets makes it a true standout in the medical field. Medical professionals administer it orally or through injection with great precision, being well aware of the gravity of the situation. Its effectiveness and safety are at the forefront of their priorities, and they observe its effects closely. Synonyms: (2R,3R,4S)-2-(acetoxymethyl)-5-((2-amino-6-hydroxy-9H-purin-9-yl)methyl)tetrahydrofuran-3,4-diyl Acetate. Molecular formula: C17H21N5O8. Mole weight: 423.38. | |
| (2R,3R,4S)-2-(Acetoxymethyl)-5-((2-amino-7-benzyl-6-hydroxy-7H-purin-9(8H)-yl)methyl)tetrahydrofuran-3,4-diyl diacetate | (2R,3R,4S)-2-(Acetoxymethyl)-5-((2-amino-7-benzyl-6-hydroxy-7H-purin-9(8H)-yl)methyl)tetrahydrofuran-3,4-diyl diacetate is an intricate chemical compound, harboring potential for combating viral afflictions. Originating from the vast purine family, this derivative plays frequent roles in antiviral therapeutics research, particularly aiming its molecular machinery towards RNA viruses. Synonyms: (2R,3R,4S)-2-(acetoxymethyl)-5-((2-amino-7-benzyl-6-hydroxy-7H-purin-9(8H)-yl)methyl)tetrahydrofuran-3,4-Diyl sodium diacetate. Molecular formula: C24H29N5O8. Mole weight: 515.52. | |
| (2R,3R,4S)-3,4-Dihydroxy-2,4-pyrrolidinedimethanol | (2R,3R,4S)-3,4-Dihydroxy-2,4-pyrrolidinedimethanol, a paramount compound extensively employed in the biomedicine sector, exhibits remarkable significance as a potent intermediary in the pharmaceutical drug synthesis process. This compound specifically serves the purpose of formulating medications intended to combat ailments related to metabolic disorders or neurological conditions. Synonyms: isoDMDP; 2,4-Pyrrolidinedimethanol, 3,4-dihydroxy-, (2R,3R,4S)-. CAS No. 1322748-73-1. Molecular formula: C6H13NO4. Mole weight: 163.17. | |
| (2R,3R,4S)-3,4-Dihydroxy-2-(hydroxymethyl)-1-pyrrolidineacetic acid | (2R,3R,4S)-3,4-Dihydroxy-2-(hydroxymethyl)-1-pyrrolidineacetic acid is a vital compound extensively used in the biomedical industry. It acts as a key intermediate in the synthesis of various drugs, including antiviral agents and anti-cancer therapies. Additionally, this compound plays a crucial role in the treatment of certain diseases caused by microbial infections, thanks to its potent antimicrobial properties. Its unique chemical structure and versatile nature make it an indispensable component in the field of biomedicine. Synonyms: 1-Pyrrolidineacetic acid, 3,4-dihydroxy-2-(hydroxymethyl)-, (2R,3R,4S)-. CAS No. 1207673-78-6. Molecular formula: C7H13NO5. Mole weight: 191.18. | |
| (2R,3R,4S,5R)-2-(4-Aminothieno[3,4-d]pyrimidin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol | (2R,3R,4S,5R)-2-(4-Aminothieno[3,4-D]pyrimidin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol is a biomedical compound, assuming a pivotal role as an intermediate within Osimertinib's synthesis process. Notably, Osimertinib manifests itself as a therapeutic intervention for Non-small cell lung cancer inflicted with distinct EGFR mutations. Synonyms: 7-(b-D-Ribofuranosyl)thieno[3,4-d]pyrimidine-4-amine. Grade: 98%. CAS No. 152615-84-4. Molecular formula: C11H13N3O4S. Mole weight: 283.30. | |
| (2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-N-methyl-2-pyrrolidine carboxamide | (2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-N-methyl-2-pyrrolidine carboxamide is a remarkable and indispensable pharmaceutical compound utilized extensively in the biomedical sector. With its intricate chemical composition and distinctive mechanism of action, this compound has garnered significant attention for its profound therapeutic properties against a multitude of diseases, particularly in tackling drug-resistant cancer types, neurological disorders, and infectious ailments. Synonyms: 2-Pyrrolidinecarboxamide, 3,4-dihydroxy-5-(hydroxymethyl)-N-methyl-, (2R,3R,4S,5R)-; (2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-N-methyl-2-pyrrolidinecarboxamide. CAS No. 1591783-03-7. Molecular formula: C7H14N2O4. Mole weight: 190.20. | |
| (2R,3R,4S,5R,6S)-3,4,5-Trihydroxy-2-hydroxymethyl-7,9-diaza-1-oxa-spiro[4,5]decane-10-one-8-thione | (2R,3R,4S,5R,6S)-3,4,5-Trihydroxy-2-hydroxymethyl-7,9-diaza-1-oxa-spiro[4,5]decane-10-one-8-thione is a chemical compound that has potential use in the treatment of some types of cancer due to its ability to inhibit cell proliferation. It has also been investigated for its antiviral properties, specifically against the HIV virus. This compound shows promise in drug development for these indications. Synonyms: 6-Oxa-1,3-diazaspiro[4.5]decan-4-one, 8,9,10-trihydroxy-7-(hydroxymethyl)-2-thioxo-, (5S,7R,8R,9S,10R)-; (5S,7R,8R,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2-thioxo-6-oxa-1,3-diazaspiro[4.5]decan-4-one; 6-Oxa-1,3-diazaspiro[4.5]decan-4-one, 8,9,10-trihydroxy-7-(hydroxymethyl)-2-thioxo-, [5S-(5α,7α,8α,9α,10β)]-. CAS No. 189633-62-3. Molecular formula: C8H12N2O6S. Mole weight: 264.26. | |
| (2R,3R,4S,5S)-2-[(1R)-1,2-Dihydroxyethyl]-3,4-dihydroxy-1-oxa-6,9-diazaspiro[4.5]decane-7,10-dione | (2R,3R,4S,5S)-2-[(1R)-1,2-Dihydroxyethyl]-3,4-dihydroxy-1-oxa-6,9-diazaspiro[4.5]decane-7,10-dione is a biomedical product utilized for its potential therapeutic applications in the research of various diseases. It exhibits a unique chemical structure that allows it to interact with specific cellular targets, aiding in the treatment of conditions such as cancer, cardiovascular disorders, or neurological diseases. Synonyms: (2R,3R,4S,5S)-2-((R)-1,2-dihydroxyethyl)-3,4-dihydroxy-1-oxa-6,9-diazaspiro[4.5]decane-7,10-dione. Molecular formula: C9H14N2O7. Mole weight: 262.22. | |
| (2R,3R,4S,5S,6R)-5-(((2S,4R,5S,6S)-5-((tert-Butyldimethylsilyl)oxy)-4-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2-(((1S,5R,6R,7E,9E,12R,16R,18R,19R)-16-((tert-butyldimethylsilyl)oxy)-6-((((2R,3R,4S,5R,6R)-5-((tert-butyldimethylsilyl)oxy)-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)-5-ethyl-8,12,18-trimethyl-3,11-dioxo-4,17-dioxabicyclo[12.3.2]nonadeca-7,9-dien-19-yl)oxy)-4-(dimethylamino)-6-methyltetrahydro-2H-pyran-3-yl acetate | An intermediate in synthesizing Tylosin. Tylosin is a macrolide antibiotic isolated from a strain of Streptomycetes fradiae found in soil from Thailand. Antibacterial. Molecular formula: C66H121NO18Si3. Mole weight: 1300.92. | |
| (2R,3R,5R)-3-(Benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-1H-purin-9(6H)-yl)-2-((benzyloxy)methyl)cyclopentanone | (2R,3R,5R)-3-(Benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-1H-purin-9(6H)-yl)-2-((benzyloxy)methyl)cyclopentanone is an intermediate in the synthesis of Entecavir, an oral antiviral drug used in the treatment of hepatitis B infection. Molecular formula: C52H49N5O5. Mole weight: 823.98. | |
| (2R,3R,5R)-5-[2-Amino-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-cyclopentanol | (2R,3R,5R)-5-[2-Amino-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-cyclopentanol is an intermediate in the preparation of ent-Entecavir. Molecular formula: C32H33N5O4. Mole weight: 551.64. | |
| (2R,3R,5R)-5-(4-Amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-4,4-difluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol | (2R,3R,5R)-5-(4-Amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-4,4-difluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol is a breakthrough drug that shows promise in the biomedical sphere. Its potential lies in its ability to act as an inhibitor for enzymes which are responsible for DNA replication and repair, thus proving lethal to swiftly dividing cancer cells and viral particles. Distinctive chemical base and mode of operation grants it a targeted high-effectivity therapeutic option for the cure of cancer and viral infections. Synonyms: (2R,3R,5R)-5-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-4,4-difluoro-2-(hydroxymethyl)tetrahydrofuran-3-alcohol. CAS No. 156058-35-4. Molecular formula: C11H12F2N4O3. Mole weight: 286.23. | |
| (2R,3R,6S)-6-(4-Fluorophenyl)tetrahydro-2-(4-hydroxyphenyl)-2H-pyran-3-carboxylic Acid | An impurity of Ezetimibe. Ezetimibe inhibits intestinal cholesterol absorption by preventing cholesterol uptake by the Niemann-Pick C1-like 1 (NPC1L17) protein, a cholesterol transporter located in the apical membrane of enterocytes. Synonyms: Ezetimibe Impurity 37. CAS No. 1618657-31-0. Molecular formula: C18H17FO4. Mole weight: 316.32. | |
| (2R,3R,6S)-Ezetimibe tetrahydropyran analog | An impurity of Ezetimibe. Ezetimibe inhibits intestinal cholesterol absorption by preventing cholesterol uptake by the Niemann-Pick C1-like 1 (NPC1L1) protein, a cholesterol transporter located in the apical membrane of enterocytes. Synonyms: Ezetimibe Tetrahydropyran Impurity; (2R,3R,6S)-N,6-Bis(4-fluorophenyl)tetrahydro-2-(4-hydroxyphenyl)-2H-pyran-3-carboxamide; (2R,3R,6S)-N,6-Bis(4-fluorophenyl)-2-(4-hydroxyphenyl)tetrahydro-2H-pyran-3-carboxamide; (2R,3R,6S)-Ezetimibe Tetrahydropyran Impurity; (2R,3R,6S)-Ezetimibe THP analog; (2R,3R,6S)-Ezetimibe Cyclized Impurity. Grade: >95%. CAS No. 1296129-15-1. Molecular formula: C24H21F2NO3. Mole weight: 409.44. | |
| (2R,3R)-E1R | (2R,3R)-E1R is a potential positive allosteric modulators of sigma-1 receptor. Synonyms: (4R,5R)-2-Oxo-4alpha-phenyl-5beta-methylpyrrolidine-1-acetamide. Grade: 98%. CAS No. 1400888-63-2. Molecular formula: C13H16N2O2. Mole weight: 232.28. | |
| (2R,3'R)-Glycopyrrolate Bromide | (2R,3'R)-Glycopyrrolate Bromide is a synthetic, quaternary ammonium anticholinergic. It has the ability to reduce the frequency of drooling in vivo with developmental disabilities. Antispasmodic. Synonyms: Ritropirronium bromide; (R,R)-Glycopyrrolate; Glycopyrronium Bromide EP Impurity N; Glycopyrrolate Erythro Isomer (RR-Isomer). Grade: 98%. CAS No. 475468-09-8. Molecular formula: C19H28BrNO3. Mole weight: 398.33. | |
| (2R,3S,11bR)-Dihydrotetrabenazine | (2R,3S,11bR)-Dihydrotetrabenazine is an impurity of Tetrabenazine, which is a VMAT inhibitor used in the treatment of hyperkinetic movement disorder. Synonyms: (2R,3S,11bR)-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol; Tetrabenazine Related Impurity 11 (2R,3S,11bR); (2R,3S,11bR)-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11bhexahydro-2H-pyrido[2,1-a]isoquinolin-2-ol. Grade: 98%. CAS No. 862377-31-9. Molecular formula: C19H29NO3. Mole weight: 319.44. | |
| (2R,3S,11bR)-Dihydrotetrabenazine D-Val | (2R,3S,11bR)-Dihydrotetrabenazine D-Val is an impurity of Tetrabenazine, which is a VMAT inhibitor used in the treatment of hyperkinetic movement disorder. Synonyms: (2R,3S,11bR)-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido(2,1-a)isoquinolin-2-yl D-valinate; D-Valine (2R,3S,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester. CAS No. 2470279-15-1. Molecular formula: C24H38N2O4. Mole weight: 418.57. | |
| (2R,3S,11bR)-Dihydrotetrabenazine-L-Val | (2R,3S,11bR)-Dihydrotetrabenazine-L-Val is an impurity of Tetrabenazine, which is a VMAT inhibitor used in the treatment of hyperkinetic movement disorder. Synonyms: (2R,3S,11bR)-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido(2,1-a)isoquinolin-2-yl L-valinate; L-Valine (2R,3S,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester. Molecular formula: C24H38N2O4. Mole weight: 418.57. | |
| (2R,3S,11bS)-Dihydrotetrabenazine | (2R,3S,11bS)-Dihydrotetrabenazine is an impurity of Tetrabenazine, which is a VMAT inhibitor used in the treatment of hyperkinetic movement disorder. Synonyms: (2R,3S,11bS)-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol; (2R,3S,11bS)-DHTBZ; (2R,3S,11bS)-3-Isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-ol; cis(2,3)-Dihydro Tetrabenazine; Tetrabenazine Related Impurity 7 (2R,3S,11bS). Grade: 98%. CAS No. 924854-62-6. Molecular formula: C19H29NO3. Mole weight: 319.44. | |
| (2R,3S,11bS)-Dihydrotetrabenazine L-Val | (2R,3S,11bS)-Dihydrotetrabenazine L-Val is an impurity of Tetrabenazine, which is a VMAT inhibitor used in the treatment of hyperkinetic movement disorder. Synonyms: (2R,3S,11bS)-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido(2,1-a)isoquinolin-2-yl L-valinate; L-Valine (2R,3S,11bS)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester. Molecular formula: C24H38N2O4. Mole weight: 418.57. | |
| (2R,3S)-3-amino-2-((Z)-2-(2-aminothiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetamido)butanoic acid | It's one of Aztreonam impurities, Aztreonam is a monobactam antibiotic used primarily to treat gram-negative bacterial infections. Grade: 95%. Molecular formula: C13H19N5O6S. Mole weight: 373.38. | |
| (2R,3S,4R)-3,4-Dihydroxy-2,4-pyrrolidinedimethanol hydrochloride | (2R,3S,4R)-3,4-Dihydroxy-2,4-pyrrolidinedimethanol hydrochloride, a crucial compound extensively utilized in the field of biomedicine, exhibits remarkable antioxidant attributes. It plays a pivotal role in the advancement of pharmaceutical therapies targeting ailments associated with oxidative stress. By acting as a fundamental element within the medication synthesis process, it aids in the alleviation of detrimental consequences caused by oxidative stress, ultimately reinstating harmonious cellular equilibrium. Molecular formula: C6H14ClNO4. Mole weight: 199.63. | |
| (2R,3S,4R)-3,4-Dihydroxypyrrolidine-2-carboxylic acid | (2R,3S,4R)-3,4-Dihydroxypyrrolidine-2-carboxylic acid is a vital compound in the field of biomedicine. It plays a significant role in the development of drugs aimed at treating various diseases. This compound can potentially be utilized in the synthesis of pharmaceuticals targeting neurological disorders, cancer, and inflammation due to its unique chemical structure and properties. Its precise applications depend on ongoing research and development within the biomedical industry. Synonyms: D-Proline, 3,4-dihydroxy-, (3S,4R)-; (3S,4R)-3,4-Dihydroxy-D-proline; D-Proline, 3,4-dihydroxy-, (2α,3β,4β)-; (2R,3S,4R)-3,4-Dihydroxyproline. CAS No. 105118-17-0. Molecular formula: C5H9NO4. Mole weight: 147.13. | |
| (2R,3S,4R,5R)-2-azido-2-((benzoyloxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl dibenzoate | (2R,3S,4R,5R)-2-azido-2-((benzoyloxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl dibenzoate, a remarkable biomedicine, emerges as a frontrunner in combating viral infections. Its extraordinary antiviral properties have captivated the attention of scientific researchers, fueling an extensive exploration of its potential in suppressing viral replication. Encouragingly, this compound demonstrates impressive efficacy in thwarting the enzymatic activity of crucial viral enzymes, rendering it an auspicious contender for addressing diverse viral afflictions. Synonyms: (2R,3S,4R,5R)-2-azido-2-((benzoyloxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidine-1(2H)-yl)tetrahydrofuran-3,4-dibenzoate diethyl. Grade: 97%. CAS No. 1365255-42-0. Molecular formula: C30H23N5O9. Mole weight: 597.53. | |
| (2R,3S,4R,5R)-2-Azido-2-((benzoyloxy)methyl)-5-(2-oxo-4-(1H-1,2,4-triazol-1-yl)pyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl dibenzoate | (2R,3S,4R,5R)-2-Azido-2-((benzoyloxy)methyl)-5-(2-oxo-4-(1H-1,2,4-triazol-1-yl)pyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl dibenzoate, a complex chemical compound, serves as a vital pharmaceutical intermediate essential for synthesizing potent nucleotide analogs with anti-cancer and anti-viral properties. Its utility compels us to leverage this intricate compound in the synthesis of efficacious drugs that can molecularly act against formidable cellular mechanisms, shielding us against devastating illnesses, and offering a new vista of life-prolonging therapeutic alternatives. Synonyms: (2R,3S,4R,5R)-2-azido-2-((benzoyloxy)methyl)-5-(2-oxo-4-(1H-1,2,4-tri(Azol-1-yl)pyrimidine 1(2H)-yl)tetrahydrofuran-3,4-diyl dibenzoate. Grade: 95%. Molecular formula: C32H24N8O8. Mole weight: 648.58. | |
| (2R,3S,4R,5R,6S)-5-Acetamido-6-(((2R,3S,4R,5R,6S)-5-acetamido-6-(benzyloxy)-2-((benzyloxy)methyl)-4-(((R)-1-oxo-1-(1,2,2-triacetylhydrazinyl)propan-2-yl)oxy)tetrahydro-2H-pyran-3-yl)oxy)-2-(acetoxymethyl)tetrahydro-2H-pyran-3,4-diyl Diacetate | (2R,3S,4R,5R,6S)-5-Acetamido-6-(((2R,3S,4R,5R,6S)-5-acetamido-6-(benzyloxy)-2-((benzyloxy)methyl)-4-(((R)-1-oxo-1-(1,2,2-triacetylhydrazinyl)propan-2-yl)oxy)tetrahydro-2H-pyran-3-yl)oxy)-2-(acetoxymethyl)tetrahydro-2H-pyran-3,4-diyl Diacetate is a by-product in the synthesis of N-Acetyl-D-glucosaminyl-(1-4)-N-acetylmuramic Acid. N-Acetyl-D-glucosaminyl-(1-4)-N-acetylmuramic Acid is effective in activating human monocytes with subsequent destruction of tumor cells. Molecular formula: C45H58N4O18. Mole weight: 942.96. | |
| (2R,3S,4R,5R,6S)-5-Acetamido-6-(benzyloxy)-2-((benzyloxy)methyl)-4-((1-oxo-1-(1,2,2-triacetylhydrazinyl)propan-2-yl)oxy)tetrahydro-2H-pyran-3-yl Acetate | (2R,3S,4R,5R,6S)-5-Acetamido-6-(benzyloxy)-2-((benzyloxy)methyl)-4-((1-oxo-1-(1,2,2-triacetylhydrazinyl)propan-2-yl)oxy)tetrahydro-2H-pyran-3-yl Acetate is a by-product in the synthesis of N-Acetyl-D-glucosaminyl-(1-4)-N-acetylmuramic Acid. N-Acetyl-D-glucosaminyl-(1-4)-N-acetylmuramic Acid is effective in activating human monocytes with subsequent destruction of tumor cells. Synonyms: (2R,3S,4R,5R,6S)-5-acetamido-6-(benzyloxy)-2-((benzyloxy)methyl)-4-((1-oxo-1-(1,2,2-triacetylhydrazineyl)propan-2-yl)oxy)tetrahydro-2H-pyran-3-yl acetate. Molecular formula: C33H41N3O11. Mole weight: 655.69. | |
| (2R,3S,4R,5S)-2-acetoxymethyl-4-acetoxy-5-azido-1,3-di-O-benzyl-piperidine | (2R,3S,4R,5S)-2-acetoxymethyl-4-acetoxy-5-azido-1,3-di-O-benzyl-piperidine is a specialized compound in the biomedical field, primarily known for its applications in pharmaceutical synthesis. It is commonly used in the manufacture of antiviral drugs, especially for the treatment and management of HIV/AIDS. Synonyms: 3,6-Di-O-acetyl-2-azido-4-O,N-di-O-benzyl-2-deoxy-D-galactonojirimycin; 2-Piperidinemethanol, 4-(acetyloxy)-5-azido-3-(phenylmethoxy)-1-(phenylmethyl)-, 2-acetate, (2R,3S,4R,5S)-. CAS No. 1227636-89-6. Molecular formula: C24H28N4O5. Mole weight: 452.50. | |
| (2R,3S,4R,5S)-2-Methyl-1-nonyl-3,4,5-piperidinetriol | (2R,3S,4R,5S)-2-Methyl-1-nonyl-3,4,5-piperidinetriol is a biomedical compound with applications in the research of ameliorating neurological impairments, cardiovascular anomalies, and metabolic dysregulations. Synonyms: N-Nonyl-1,6-dideoxygalactonojirimycin; 3,4,5-Piperidinetriol, 2-methyl-1-nonyl-, (2R,3S,4R,5S)-; (2R,3S,4R,5S)-Methyl-1-nonyl-3,4,5-piperidinetriol. CAS No. 324760-01-2. Molecular formula: C15H31NO3. Mole weight: 273.41. | |
| (2R,3S,4R,5S)-3,4-Dihydroxy-2,5-pyrrolidinedimethanol | (2R,3S,4R,5S)-3,4-Dihydroxy-2,5-pyrrolidinedimethanol, a highly sought-after compound in the biomedical industry, exhibits immense potential in addressing metabolic disorders. With its profound impact on glucose metabolism and insulin sensitivity, it emerges as a prime contender for novel drug development targeting diabetes and allied ailments. The complex molecular arrangement and distinctive biochemical attributes of this compound render it a vital constituent in the perpetual quest for enhanced therapeutic interventions against metabolic diseases. Synonyms: 2,5-Pyrrolidinedimethanol, 3,4-dihydroxy-, (2R,3S,4R,5S)-. CAS No. 250128-99-5. Molecular formula: C6H13NO4. Mole weight: 163.17. | |
| (2R,3S,4R,5S)-3,4-Dihydroxy-3,4-O-isopropylidene-2,5-bis-[(tert-butyldimethylsilyloxy)methyl]-1-benzyl-2-pyrrolidine | (2R,3S,4R,5S)-3,4-Dihydroxy-3,4-O-isopropylidene-2,5-bis-[(tert-butyldimethylsilyloxy)methyl]-1-benzyl-2-pyrrolidine, a scientifically significant pharmaceutical compound, emerges as a pivotal agent in the treatment of a multitude of ailments. Its prominent role in the biomedical industry revolves around exerting potent anti-inflammatory effects, with a primary focus on alleviating autoimmune disorders like rheumatoid arthritis and multiple sclerosis. By adeptly suppressing the production of pro-inflammatory molecules, this unparalleled compound offers respite to afflicted patients grappling with these debilitating conditions. | |
| (2R,3S,4R,5S)-3,4-Di-O-Isopropylidene-2-methyl-1-nonyl-3,4,5-piperidinetriol | (2R,3S,4R,5S)-3,4-Di-O-Isopropylidene-2-methyl-1-nonyl-3,4,5-piperidinetriol is an indispensable compound, playing a pivotal role in the research of malignancies, cardiac ailments and neurodegenerative maladies. Its distinctive molecular framework facilitates targeted interactions with specific cellular receptors, thereby enabling the development of new drugs. Synonyms: Adenosine, 2'-deoxy-1,6-dihydro-1-methyl-; (2R,3S,5R)-5-(6-Amino-1-methyl-1,6-dihydro-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol. CAS No. 3413-67-0. Molecular formula: C11H17N5O3. Mole weight: 267.28. | |
| (2R,3S,4R,5S)-3,4-O-Isopropylidene-2-butyl-3,4,5-piperidinetriol | (2R,3S,4R,5S)-3,4-O-Isopropylidene-2-butyl-3,4,5-piperidinetriol, aptly deemed a significant compound within the biomedical sector, assumes a paramount role in addressing a multitude of diseases and ailments, encompassing diabetes, cancer, and cardiovascular disorders. As an essential constituent of groundbreaking medicinal concoctions, this unparalleled product exhibits a distinctive chemical architecture and traits that are indispensable in formulating efficacious therapeutic interventions. Molecular formula: C12H23NO3. Mole weight: 229.32. | |
| (2R,3S,4R,5S)-3,4-O-Isopropylidene-2-methyl-3,4,5-piperidinetriol | (2R,3S,4R,5S)-3,4-O-Isopropylidene-2-methyl-3,4,5-piperidinetriol, an essential component in the biomedical sector, holds immense importance for drug discovery. Its significance lies in the formulation of targeted medications addressing a broad range of medical ailments including cancer, neurodegenerative disorders, and cardiovascular conditions. This compound's distinct molecular arrangement and inherent characteristics render it an ideal candidate for the creation of efficacious therapeutic interventions. Its versatile nature paves the way for groundbreaking advancements in the realm of medicine, facilitating novel approaches to combat complex diseases plaguing mankind. Synonyms: (3aS,4R,7S,7aR)-2,2,4-trimethylhexahydro-[1,3]dioxolo[4,5-c]pyridin-7-ol; 1,2,6-Trideoxy-2,6-imino-3,4-O-(1-methylethylidine)-D-galactitol; 2,6-imino-3,4-O-ipr-galactitol; (3aS,4R,7S,7aR)-Hexahydro-2,2,4-trimethyl-1,3-dioxolo[4,5-c]pyridin-7-ol. CAS No. 324759-96-8. Molecular formula: C9H17NO3. Mole weight: 187.24. | |
| (2R,3S,4S)-3,4-Dihydroxy-N-methyl-2-pyrrolidine carboxamide | (2R,3S,4S)-3,4-Dihydroxy-N-methyl-2-pyrrolidine carboxamide is a compound showcasing remarkable activity against diverse drug-resistant pathogens and exhibiting promising research outcomes in the battle against microbial infections. Synonyms: 2-Pyrrolidinecarboxamide, 3,4-dihydroxy-N-methyl-, (2R,3S,4S)-; (2R,3S,4S)-3,4-Dihydroxy-N-methyl-2-pyrrolidinecarboxamide. CAS No. 2055610-35-8. Molecular formula: C6H12N2O3. Mole weight: 160.17. | |
| (2R,3S,4S)-4-(Azidomethyl)-3-fluoro-1-(phenylmethyl)-2-azetidinecarboxylic acid methyl ester | (2R,3S,4S)-4-(Azidomethyl)-3-fluoro-1-(phenylmethyl)-2-azetidinecarboxylic acid methyl ester, commonly known as AFPA, is a highly effective biomedical solution designed to combat drug-resistant bacterial infections. With its distinctive chemical composition, AFPA demonstrates exceptional antimicrobial efficacy against a vast range of bacteria, including those strains that have developed resistance to conventional treatments. Through the inhibition of bacterial growth and replication, AFPA plays a pivotal role in tackling diverse bacterial infections, thereby significantly enhancing patient outcomes. Synonyms: 2-Azetidinecarboxylic acid, 4-(azidomethyl)-3-fluoro-1-(phenylmethyl)-, methyl ester, (2R,3S,4S)-; Methyl (2R,3S,4S)-4-(azidomethyl)-3-fluoro-1-(phenylmethyl)-2-azetidinecarboxylate. CAS No. 1701465-42-0. Molecular formula: C13H15FN4O2. Mole weight: 278.28. | |
| (2R,3S,4S,5R)-2-(Acetoxymethyl)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate | (2R,3S,4S,5R)-2-(Acetoxymethyl)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate, a chemical compound oft utilized by the pharmaceutical industry as an intermediate for the synthesis of other compounds, has yet to be rigorously studied for efficacy in treating specific ailments. Its function remains elusive, but its potential in constructing medicinal substances warrants further examination. Synonyms: (2R,3S,4S,5R)-2-(acetoxymethyl)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidine-1(2H)-Yl)tetrahydrofuran-3,4-diyl diacetate. Grade: 95%. Molecular formula: C15H17N5O9. Mole weight: 411.32. | |
| (2R,3S,4S,5R)-2-(Hydroxymethyl)-5-methyl-3,4-pyrrolidinediol | (2R,3S,4S,5R)-2-(Hydroxymethyl)-5-methyl-3,4-pyrrolidinediol is a key ingredient used in the development of drugs aimed at treating various diseases. With its unique molecular structure, it exhibits promising therapeutic potential for combating certain infections and cancers. This product plays a crucial role in the biomedical industry as it serves as a building block for synthesizing advanced pharmaceutical agents targeting specific pathogens or malignant cells. Synonyms: 3,4-Pyrrolidinediol, 2-(hydroxymethyl)-5-methyl-, (2R,3S,4S,5R)-. CAS No. 1932460-16-6. Molecular formula: C6H13NO3. Mole weight: 147.17. | |
| (2R,3S,4S,5R)-3-(3,4-Difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carbonitrile | An intermediate of Suzetrigine, which is an oral selective NaV1.8 pain signal inhibitor developed for the treatment of moderate-to-severe acute pain. Synonyms: 2-Furancarbonitrile, 3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-, (2R,3S,4S,5R)-; (2R,3S,4S,5R)-3-(3,4-Difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furancarbonitrile. Grade: ≥95%. CAS No. 2875067-17-5. Molecular formula: C15H14F5NO2. Mole weight: 335.27. | |
| (2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-N-methyl-2-pyrrolidine carboxamide | (2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-N-methyl-2-pyrrolidine carboxamide, an exceptionally powerful and groundbreaking medicinal substance extensively utilized in the biomedical arena, manifests a remarkable capacity to combat and counteract a diverse range of ailments encompassing cancer, HIV/AIDS, and autoimmune disorders. Its distinguishing molecular framework endows it with the remarkable ability to intricately engage with specific enzymes and receptors, thereby proficiently impeding their operation while concurrently facilitating the management of debilitating diseases. Synonyms: 2-Pyrrolidinecarboxamide, 3,4-dihydroxy-5-(hydroxymethyl)-N-methyl-, (2R,3S,4S,5R)-; (2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-N-methyl-2-pyrrolidinecarboxamide. CAS No. 1591782-83-0. Molecular formula: C7H14N2O4. Mole weight: 190.20. | |
| (2R,3S,4S,5R)-3-Hydroxy-5-[(methylamino)carbonyl]-4-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester | (2R,3S,4S,5R)-3-Hydroxy-5-[(methylamino)carbonyl]-4-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester is a compound widely studied in biomedicine, exhibiting significant potential in the treatment of a wide range of diseases. Its mechanism of action involves targeting specific molecular pathways and receptors linked to drug-resistant cancers, neurodegenerative disorders, and infectious diseases. Synonyms: 1-Pyrrolidinecarboxylic acid, 3-hydroxy-5-[(methylamino)carbonyl]-4-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, 1,1-dimethylethyl ester, (2R,3S,4S,5R)-; 1,1-Dimethylethyl (2R,3S,4S,5R)-3-hydroxy-5-[(methylamino)carbonyl]-4-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-1-pyrrolidinecarboxylate. CAS No. 1591782-89-6. Molecular formula: C26H34N2O6. Mole weight: 470.56. | |
| (2R,3S,4S,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate | (2R,3S,4S,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, a pharmaceutical compound used in cancer treatment, exhibits potent anticancer activity while showing minimal toxicity towards normal cells. By selectively inhibiting DNA synthesis in cancer cells, this drug has proven effective against various tumor types. Promising as an agent in cancer therapy, this compound's potential lies in its unique ability to target cancer cells while minimizing detrimental side effects. Molecular formula: C31H26FN3O7. Mole weight: 571.55. | |
| (2R,3S,4S,5R,6R)-2-(Acetoxymethyl)-6-(2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-2-oxoethoxy)tetrahydro-2H-pyran-3,4,5-triyl Triacetate | (2R,3S,4S,5R,6R)-2-(Acetoxymethyl)-6-(2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-2-oxoethoxy)tetrahydro-2H-pyran-3,4,5-triyl Triacetate is an intermediate in the synthesis of Cyanidin 3-O-β-D-Galactopyranoside Chloride. An anthocyanin responsible for red pigment in fruits and berries. Cyanidin 3-O-β-D-Galactopyranoside Chloride is an antioxidant, protecting the cell against damage from SOD. Synonyms: 1-(2,2-Diphenyl-1,3-benzodioxol-5-yl)-2-[(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)oxy]ethanone. Molecular formula: C35H34O13. Mole weight: 662.64. | |
| (2R,3S,4S,5R,6S)-2-(Acetoxymethyl)-6-(((E)-1,4-diacetoxy-2,5-dihydroxy-6-(2-(phthalazin-1-yl)hydrazono)hexan-3-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl Triacetate | (2R,3S,4S,5R,6S)-2-(Acetoxymethyl)-6-(((E)-1,4-diacetoxy-2,5-dihydroxy-6-(2-(phthalazin-1-yl)hydrazono)hexan-3-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl Triacetate is an intermediate in the synthesis of Hydralazine Lactosone Ring-opened Adduct. Hydralazine Lactosone Ring-opened Adduct is a derivative of Lactose. Molecular formula: C32H40N4O16. Mole weight: 736.68. | |
| (2R,3S,4S,5R,6S)-3,4,5-Trihydroxy-2-hydroxymethyl-7,9-diaza-1-oxa-spiro[4,5]decane-10-one-8-thione | (2R,3S,4S,5R,6S)-3,4,5-Trihydroxy-2-hydroxymethyl-7,9-diaza-1-oxa-spiro[4,5]decane-10-one-8-thione is a complex compound with great potential in treating oxidative stress, inflammation, and cancer. Its diverse pharmacological activities include antioxidant and anti-inflammatory properties, as well as the ability to trigger apoptosis in cancer cells. Ongoing research is delving deeper into its therapeutic potentials for numerous debilitating conditions. Synonyms: 6-Oxa-1,3-diazaspiro[4.5]decan-4-one, 8,9,10-trihydroxy-7-(hydroxymethyl)-2-thioxo-, (5S,7R,8S,9S,10R)-; (5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2-thioxo-6-oxa-1,3-diazaspiro[4.5]decan-4-one. CAS No. 227458-60-8. Molecular formula: C8H12N2O6S. Mole weight: 264.26. | |
| (2R,3S,4S,5S)-2-Methyl-3,4,5-piperidinetriol | (2R,3S,4S,5S)-2-Methyl-3,4,5-piperidinetriol, a highly significant compound, holds immense importance in the biomedical sector. It serves as a pivotal agent in treating an array of ailments and conditions, encompassing cardiovascular, neurological, and metabolic disorders. Synonyms: 5-epi-Deoxyrhamnojirimycin; 1,5,6-trideoxy-1,5-imino-D-gulitol; 3,4,5-Piperidinetriol, 2-methyl-, (2R,3S,4S,5S)-; 3,4,5-Piperidinetriol, 2-methyl-, [2R-(2α,3α,4β,5β)]-. CAS No. 135395-58-3. Molecular formula: C6H13NO3. Mole weight: 147.17. | |
| (2R,3S,4S,5S)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate | (2R,3S,4S,5S)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate is a biomedical compound, serving as a potent therapeutic agent combating a myriad of diseases. Fascinatingly, it exhibits an impressive propensity for selectively engaging specific enzymes implicated in the advancement of malignancies and viral afflictions. Synonyms: CS-0009865; (2R,3S,4S,5S)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate. Molecular formula: C31H26FN3O7. Mole weight: 571.55. | |
| (2R,3S,4S,5S)-5-Hydroxy-2,3,4-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl]-cyclohexyl-(R)-amino-3-phenoxypropanal | (2R,3S,4S,5S)-5-Hydroxy-2,3,4-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl]-cyclohexyl-(R)-2-amino-3-phenoxypropanal is an intermediate used in the synthesis of (S)-Valiolamine Voglibose Dihydrochloride, which is the main S-enantiomeric intermediate of Voglibose, an α-glucosidase inhibitor that works by delaying the digestion and absorption of carbohydrates, thereby inhibiting postprandial hyperglycemia and hyperinsulinemia. Synonyms: (R)-3-phenoxy-2-(((1S,2S,3R,4S,5S)-2,3,4-tris(benzyloxy)-5-((benzyloxy)methyl)-5-hydroxycyclohexyl)amino)propanal. Molecular formula: C44H47NO7. Mole weight: 701.85. | |
| (2R,3S,5R)-5-(4-Amino-5-methyl-2-oxopyrimidin-1(2H)-yl)-2-(((4-methylbenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-Methylbenzoate-13C,15N2 | (2R,3S,5R)-5-(4-Amino-5-methyl-2-oxopyrimidin-1(2H)-yl)-2-(((4-methylbenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-Methylbenzoate-13C,15N2 is an intermediate used in the synthesis of 5-Methyl-2'-deoxy Cytidine-13C,15N2, which is an isotopic analog of 5-Methyl-2'-deoxy Cytidine, a Cytidine analog and also an isostere of Thymidine. Molecular formula: C25[13C]H27N[15N]2O6. Mole weight: 480.49. | |
| (2R,3S,5R)-5-(5-((E)-2-bromovinyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-(((4-chlorobenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-chlorobenzoate | (2R,3S,5R)-5-(5-((E)-2-bromovinyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-(((4-chlorobenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-chlorobenzoate, an indispensable pharmaceutical intermediate, finds extensive use in drug synthesis to combat a range of illnesses like cancer, viral infections, and autoimmune disorders. Additionally, it plays a critical role in the development of intrinsic anti-inflammatory and antifungal agents, enhancing its versatility and multifaceted appeal to pharmacological researchers worldwide. Synonyms: Uridine, 5-[(1E)-2-bromoethenyl]-2'-deoxy-, 3',5'-bis(4-chlorobenzoate); (2R,3S,5R)-5-(5-((E)-2-bromovinyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-(((4-chlorobenzoyl)oxy)methyl)tetrahydrofuran-3-yl4-chlorobenzoate; [(2R,3S,5R)-5-[5-[(E)-2-bromoethenyl]-2,4-dioxopyrimidin-1-yl]-3-(4-chlorobenzoyl)oxyoxolan-2-yl]methyl 4-chlorobenzoate. Grade: 98%. CAS No. 87531-10-0. Molecular formula: C25H19BrCl2N2O7. Mole weight: 610.24. | |
| (2R,3S,5R)-5-(5-Methyl-2-oxo-4-(1H-1,2,4-triazol-1-yl)pyrimidin-1(2H)-yl)-2-(((4-methylbenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-methylbenzoate-13CH27,15N2 | (2R,3S,5R)-5-(5-Methyl-2-oxo-4-(1H-1,2,4-triazol-1-yl)pyrimidin-1(2H)-yl)-2-(((4-methylbenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-methylbenzoate-13CH27,15N2 is an intermediate in synthesizing 5-Methyl-2'-deoxy Cytidine-13C,15N2. It is an isotopic analog of 5-Methyl-2'-deoxy Cytidine, a Cytidine analog. It is also an isostere of Thymidine. Molecular formula: C27[13C]H27N3[15N]2O6. Mole weight: 532.52. | |
| (2R,3S,5S)-Tetrahydro-3-hydroxy-5-(2-propen-1-yl)-2-furanmethanol | (2R,3S,5S)-Tetrahydro-3-hydroxy-5-(2-propen-1-yl)-2-furanmethanol, an essential precursor in the production of various pharmacological agents, exhibits promising potential in the treatment of neurodegenerative maladies such as Alzheimer's and Parkinson's disease. Its diverse application and utility in synthesizing antiviral and anticancer drugs further highlight the significance of this compound in medicinal chemistry. CAS No. 1057653-79-8. Molecular formula: C8H14O3. Mole weight: 158.19. | |
| (2R,3S)-Chlorpheg | (2R,3S)-Chlorpheg is a weakly active NMDA receptor antagonist. Synonyms: (2R,3S)-β-p-Chlorophenylglutamic acid. CAS No. 140924-23-8. Molecular formula: C11H12ClNO4. Mole weight: 257.67. | |
| (2R,3S)-E1R | (2R,3S)-E1R is an enantiomer of E1R, which is a potential positive allosteric modulator of sigma-1 receptors. Synonyms: (4S,5R)-2-Oxo-4beta-phenyl-5beta-methylpyrrolidine-1-acetamide. Grade: 98%. CAS No. 1424832-60-9. Molecular formula: C13H16N2O2. Mole weight: 232.28. | |
| (2R,3'S)-Glycopyrrolate Bromide | (2R,3'S)-Glycopyrrolate Bromide is an impurity of Glycopyrrolate, which is an anticholinergic agent with antispasmodic activity used to treat gastrointestinal conditions associated. Synonyms: (3S)-3-[[(2R)-2-Cyclopentyl-2-hydroxy-2-phenylacetyl]oxy]-1,1-dimethylpyrrolidinium Bromide (1:1); Pyrrolidinium, 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl-, Bromide (1:1); (S)-3-((R)-2-Cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide; Glycopyrronium Bromide EP Impurity N; Glycopyrrolate Erythro Isomer (RS-Isomer). CAS No. 129784-12-9. Molecular formula: C19H28NO3.Br. Mole weight: 398.33. | |
Our database is helping our users find suppliers everyday.
